Virginiamycin S1
Virginiamycin S1 is a streptogramin antibiotic that is part of the virginiamycin complex. It is produced by the bacterium Streptomyces virginiae. Virginiamycin S1 is used in combination with virginiamycin M1 in the treatment of various bacterial infections.
History[edit | edit source]
Virginiamycin S1 was first isolated in the 1950s from Streptomyces virginiae found in soil samples from the state of Virginia, United States. The antibiotic was named after the state where the bacterium was first discovered.
Structure and Mechanism[edit | edit source]
Virginiamycin S1 is a macrolide antibiotic. It has a large, complex structure that allows it to bind to the 50S ribosomal subunit of bacteria, inhibiting protein synthesis. This action is synergistic with that of virginiamycin M1, which binds to a different site on the 50S subunit, leading to a more effective inhibition of protein synthesis.
Medical Use[edit | edit source]
Virginiamycin S1 is used in combination with virginiamycin M1 to treat infections caused by Gram-positive bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecium. The combination of the two antibiotics is more effective than either one alone due to their synergistic action.
Side Effects and Precautions[edit | edit source]
Like all antibiotics, virginiamycin S1 can cause side effects, including allergic reactions, nausea, vomiting, and diarrhea. It should be used with caution in patients with a history of allergy to macrolide antibiotics.
Resistance[edit | edit source]
Resistance to virginiamycin S1 can occur through several mechanisms, including modification of the antibiotic target site, active efflux of the antibiotic, and enzymatic inactivation of the antibiotic. The development of resistance is a major concern in the use of virginiamycin S1 and other antibiotics.
See Also[edit | edit source]
| This article is a stub. You can help WikiMD by registering to expand it. |
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
